Jan. 6 at 6:36 AM
$OMI
after a deep dive, I can not find anything fundamental to explain these two days huge volume selling.
I will have to conclude the selling due to following:
- Forced selling due to ticker + mandate mismatch (VERY important)
Many holders owned OMI as a diversified healthcare distributor.
ACH is now pure Patient Direct / home care.
Index funds, sector ETFs, mandates must sell.
Some systems treat ticker changes as new securities.
This alone can cause massive volume spikes.
-Wash-sale logic still matters
Investor sold OMI late Dec 2025 to lock in a 2025 loss
They must avoid repurchasing for 30 days
Result: no bid support in early January
-Balance-sheet fear is being mispriced
Market narrative: “
$2B debt, small company, risky”
Reality (post-PHS):
EBITDA ~
$380M
FCF ~
$100M
Debt/EBITDA ~ 5.3x, but declining
Stable, non-cyclical reimbursement business